Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Tumori ; 106(5): 378-387, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32623975

ABSTRACT

INTRODUCTION: Breast cancer is one of the most frequently occurring cancers during pregnancy and its incidence is increasing. Many studies have shown poor outcomes, the causes of which remain unclear. OBJECTIVES: To analyze radiologic characteristics, histology, and prognosis factors of breast cancer during pregnancy. METHODS: A total of 42 patients with breast cancer diagnosed during pregnancy (BCP) were matched with 84 patients with breast cancer of similar age who were not pregnant. Sensitivity of radiology, tumor characteristics, prognosis factors, disease-free survival, and overall survival were analyzed. RESULTS: The sensitivity of breast ultrasound was higher than that of mammography for both groups. Ultrasound sensitivity for cancer was 95.7% in patients with BCP versus 98% in the not pregnant group, with non-statistically significant differences. Mammography sensitivity for cancer was 56.5% in patients with BCP versus 61% in the not pregnant group, with non-statistically significant differences. The stage at diagnosis according to the TNM staging system was significantly higher in patients with BCP with stage IV cancer: 16.7% in patients with BCP versus 3.7% in the not pregnant group (p = 0.03). No statistically significant differences were observed in histologic grade, Ki-67 index, or molecular subtype. Disease-free survival and overall survival were significantly lower in patients with BCP (p = 0.002 and p = 0.04). Multivariate analysis showed no difference when adjusting for stage and surrogate molecular subtype. CONCLUSION: Breast ultrasound shows a high sensitivity to detect breast cancer during pregnancy. BCP is diagnosed at a higher stage than in nonpregnant women. In our series, patients with BCP had poorer outcomes than the not pregnant group. These results were not observed when adjusting for stage.


Subject(s)
Breast Neoplasms/diagnosis , Breast/diagnostic imaging , Pregnancy Complications, Neoplastic/diagnosis , Prognosis , Adult , Breast Neoplasms/complications , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/pathology , Disease-Free Survival , Female , Humans , Mammography , Neoplasm Staging , Pregnancy , Pregnancy Complications, Neoplastic/diagnostic imaging , Pregnancy Complications, Neoplastic/pathology , Survival Rate , Ultrasonography, Mammary
2.
J Low Genit Tract Dis ; 23(1): 7-12, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30161052

ABSTRACT

OBJECTIVES: The data available on vaginal intraepithelial neoplasia (VAIN) and infection by HIV are scarce. We therefore aimed to review the clinical presentation, management, and survival outcomes of VAIN in this group of women. MATERIALS AND METHODS: This is an observational cohort study of women diagnosed with VAIN for a 23-year period. Clinical characteristics and outcomes were analyzed according to women's HIV infection status. Disease-free and progression-free survival were compared between groups. RESULTS: Twenty-two of 87 women were HIV positive (25.3%) compared with the HIV-negative group, HIV-positive women were younger (median age = 39 vs 57 years, p < .001) and more frequently smokers (p < .001). They also presented with multifocal and multicentric disease more often (p = .004 and p = .033, respectively) in relation to infection by human papillomavirus. All HIV-positive women were receiving antiretroviral treatment. The median time from the diagnosis of HIV to the development of VAIN was 14 years (range = 1-22 years). There were no significant differences in survival outcomes between groups. CONCLUSIONS: HIV-positive women are at an increased risk of developing VAIN and frequently present at a younger age with multifocal and multicentric disease. Vaginal intraepithelial neoplasia lesions can develop many years after the initial diagnosis of HIV infection reason why prolonged surveillance is essential to enable prompt diagnosis and treatment.


Subject(s)
Carcinoma in Situ/diagnosis , Carcinoma in Situ/therapy , Disease Management , HIV Infections/complications , Vaginal Neoplasms/diagnosis , Vaginal Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Carcinoma in Situ/mortality , Carcinoma in Situ/pathology , Cohort Studies , Female , Humans , Middle Aged , Survival Analysis , Treatment Outcome , Vaginal Neoplasms/mortality , Vaginal Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...